Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 173, Issue 13, Pages 2080-2094
Publisher
Wiley
Online
2015-09-02
DOI
10.1111/bph.13318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid Protein Precursor: Involvement of MAPK and PKC Activation
- (2017) Orit Bar-Am et al. JOURNAL OF ALZHEIMERS DISEASE
- Aging synaptic mitochondria exhibit dynamic proteomic changes while maintaining bioenergetic function
- (2016) Kelly L. Stauch et al. Aging-US
- Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets
- (2015) Orit Bar-Am et al. JOURNAL OF NEURAL TRANSMISSION
- Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer’s disease
- (2015) Ana Knezovic et al. JOURNAL OF NEURAL TRANSMISSION
- Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease
- (2015) Melita Salkovic-Petrisic et al. LIFE SCIENCES
- Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging
- (2015) Orit Bar-Am et al. NEUROBIOLOGY OF AGING
- Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease
- (2014) Gerard Esteban et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus
- (2014) Danit Mechlovich et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Novel Multi-Target Iron Chelator, M30 Modulates HIF-1α-Related Glycolytic Genes and Insulin Signaling Pathway in the Frontal Cortex of APP/PS1 Alzheimer’s Disease Mice
- (2014) Danit Mechlovich et al. Current Alzheimer Research
- Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia
- (2014) Anna Stasiak et al. CURRENT PHARMACEUTICAL DESIGN
- Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies
- (2014) Ornella Di Pietro et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease
- (2014) Li Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Brain catalase in the streptozotocin-rat model of sporadic Alzheimer’s disease treated with the iron chelator–monoamine oxidase inhibitor, M30
- (2014) E. Sofic et al. JOURNAL OF NEURAL TRANSMISSION
- The role of iron in brain ageing and neurodegenerative disorders
- (2014) Roberta J Ward et al. LANCET NEUROLOGY
- Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease
- (2014) Yannick Vermeiren et al. NEUROBIOLOGY OF AGING
- Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release
- (2014) John P.M. Finberg PHARMACOLOGY & THERAPEUTICS
- Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
- (2014) Dmitry B. Zorov et al. PHYSIOLOGICAL REVIEWS
- The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Transporters
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro
- (2013) Irene Bolea et al. Current Alzheimer Research
- A novel series of tacrine–selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease
- (2013) Chuanjun Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease
- (2013) Chuanjun Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dose-dependent Effects of Ladostigil on Microglial Activation and Cognition in Aged Rats
- (2013) Marta Weinstock et al. Journal of Neuroimmune Pharmacology
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
- (2013) Valeria Capurro et al. PLoS One
- The Neuropsychological Profile of Alzheimer Disease
- (2013) S. Weintraub et al. Cold Spring Harbor Perspectives in Medicine
- The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease
- (2012) Lana Kupershmidt et al. ANTIOXIDANTS & REDOX SIGNALING
- O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: Multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation
- (2012) Fei Mao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Reviewing the Role of Donepezil in the Treatment of Alzheimer’s Disease
- (2012) Rachelle S. Doody et al. Current Alzheimer Research
- Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine
- (2012) Abdelouahid Samadi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Anti-Inflammatory Effects of Ladostigil and Its Metabolites in Aged Rat Brain and in Microglial Cells
- (2012) Rony Panarsky et al. Journal of Neuroimmune Pharmacology
- Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice
- (2012) Lana Kupershmidt et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus
- (2012) Sandro D. Mesquita et al. Frontiers in Cellular Neuroscience
- Insulin resistance and pathological brain ageing
- (2011) B. Cholerton et al. DIABETIC MEDICINE
- Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease
- (2011) Abdelouahid Samadi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil andN-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease
- (2011) Irene Bolea et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain
- (2011) L. Kupershmidt et al. NEUROSCIENCE
- Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases
- (2011) Wei Zheng et al. PHARMACOLOGY & THERAPEUTICS
- Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities
- (2010) Orly Weinreb et al. ANTIOXIDANTS & REDOX SIGNALING
- Up-Regulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30
- (2010) Y. Avramovich-Tirosh et al. Current Alzheimer Research
- Galantamine for Alzheimer's disease
- (2010) David Prvulovic et al. Expert Opinion on Drug Metabolism & Toxicology
- Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
- (2010) Orly Weinreb et al. PROGRESS IN NEUROBIOLOGY
- Prolyl Hydroxylase Domain Inhibitors: A Route to HIF Activation and Neuroprotection
- (2009) Sarah K. Harten et al. ANTIOXIDANTS & REDOX SIGNALING
- Therapeutic Manipulation of the HIF Hydroxylases
- (2009) Simon Nagel et al. ANTIOXIDANTS & REDOX SIGNALING
- Abnormal mitochondrial dynamics and neurodegenerative diseases
- (2009) Bo Su et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Assessment of MAO-B Occupancy in the Brain With PET and [11C]-L-Deprenyl-D2: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301
- (2009) J Hirvonen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis
- (2009) Lana Kupershmidt et al. FASEB JOURNAL
- Ladostigil prevents age-related glial activation and spatial memory deficits in rats
- (2009) Marta Weinstock et al. NEUROBIOLOGY OF AGING
- Restoration of Nigrostriatal Dopamine Neurons in Post-MPTP Treatment by the Novel Multifunctional Brain-Permeable Iron Chelator-Monoamine Oxidase Inhibitor Drug, M30
- (2009) Shunit Gal et al. NEUROTOXICITY RESEARCH
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease
- (2008) Jack T. Rogers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- (Pre)diabetes, brain aging, and cognition
- (2008) Jarbas S. Roriz-Filho et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity
- (2008) Orly Weinreb et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
- (2008) Ying Liu et al. FEBS LETTERS
- The Novel Cholinesterase–Monoamine Oxidase Inhibitor and Antioxidant, Ladostigil, Confers Neuroprotection in Neuroblastoma Cells and Aged Rats
- (2008) Orit Bar-Am et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
- (2008) C. Warren Olanow et al. MOVEMENT DISORDERS
- Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease
- (2008) Maria Laura Bolognesi et al. Neurotherapeutics
- The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?
- (2008) Hirokazu Fukui et al. TRENDS IN NEUROSCIENCES
- Prolyl 4-hydroxylase activity-responsive transcription factors: From hydroxylation to gene expression and neuroprotection
- (2007) Ambreena Siddiq Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started